Long-acting antipsychotic treatments: focus on women with schizophrenia [0.03%]
长效抗精神病药物治疗：聚焦女性精神分裂症患者
Sofia Brissos,Vicent Balanzá-Martínez
Sofia Brissos
Effective management of schizophrenia (SZ) requires long-term treatment with antipsychotics (APs) to prevent clinical relapse, attain remission and improve patients' personal and social functioning, and quality of life. Although APs remain ...
Sublingual asenapine for agitation in malabsorptive states: three patient cases [0.03%]
有关吸收不良状态下焦虑症状的三项患者个例研究：舌下含服阿塞那平治疗 agitation 在 malabsorptive 状态下的 sublingual asenapine：三个病例的研究
Bradley G Burk,Kyle Humphreys,Jim Waites et al.
Bradley G Burk et al.
Gastric malabsorptive conditions may prevent patients from deriving benefit from orally administered medications intended for enteric absorption. While malabsorption is an increasingly common issue, current data on alternative oral options ...
Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis [0.03%]
长效抗精神病药物与口服抗精神病药物治疗精神分裂症谱系障碍早期患者的疗效和安全性：系统评价和 Meta 分析
Giovanni Vita,Angelantonio Tavella,Giovanni Ostuzzi et al.
Giovanni Vita et al.
Background: Long-acting injectable antipsychotics (LAIs) have advantages over oral antipsychotics (OAPs) in preventing relapse and hospitalization in chronically ill patients with schizophrenia-spectrum disorders (SSDs), ...
Metformin co-commencement at time of antipsychotic initiation for attenuation of weight gain: a systematic review and meta-analysis [0.03%]
抗精神病药增重的二甲双胍联合治疗：系统评价和meta分析
Ou Yu,Mengyao Lu,Terence K Y Lai et al.
Ou Yu et al.
Background: Antipsychotic medications are associated with weight gain and metabolic derangement. However, comprehensive evidence for the efficacy of co-commenced pharmacological treatments to mitigate initial weight gain ...
The cardiovascular safety of tricyclic antidepressants in overdose and in clinical use [0.03%]
三环抗抑郁药在药物过量和临床使用中的心血管安全性
David Taylor,Sofia Poulou,Ivana Clark
David Taylor
Tricyclic antidepressants (TCAs) remain widely prescribed for depression and many other conditions. There may be important differences between individual TCA in regard to their overdose toxicity and their cardiac toxicity in clinical use. W...
Paralytic ileus in a patient on clozapine therapy showing an inverted clozapine/norclozapine ratio after switching valproic acid to carbamazepine: a case report [0.03%]
氯丙嗪治疗患者的麻痹性肠梗阻出现异常的氯丙嗪/norchlor丙嗪比例：从Valproic Acid换用卡马西平后的个案报告
Geke van Weringh,Leonieke van Koolwijk,Lieuwe de Haan et al.
Geke van Weringh et al.
This case report examines the possible correlation between the clozapine/norclozapine ratio and the occurrence of constipation and paralytic ileus. We present the case of a 42-year-old patient diagnosed with schizoaffective disorder undergo...
Corrigendum to "Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series" [0.03%]
司美格鲁肽治疗二甲双胍疗效不佳的抗精神病药物相关性体重增加患者的系列病例研究的勘误通知书
[This corrects the article DOI: 10.1177/20451253231165169.]. © The Author(s), 2024.
Nadia El Ouni Amami,Husen Ali-Diabacte,Sarra Ateb et al.
Nadia El Ouni Amami et al.
Clozapine, renowned for its efficacy in treatment-resistant schizophrenia, is associated with rare yet potentially severe side effects, including hematological disorders, myocarditis, seizures and gastrointestinal obstruction. Dermatologica...
Neuroimaging features of cognitive impairments in schizophrenia and major depressive disorder [0.03%]
精神分裂症和重大抑郁症的认知损伤的神经影像特征
Yu-Ting Li,Chi Zhang,Jia-Cheng Han et al.
Yu-Ting Li et al.
Cognitive dysfunctions are one of the key symptoms of schizophrenia (SZ) and major depressive disorder (MDD), which exist not only during the onset of diseases but also before the onset, even after the remission of psychiatric symptoms. Wit...
Eduardo Ekman Schenberg
Eduardo Ekman Schenberg